Review article · 2004
EMEA and the evaluation of health-related quality of life data in the drug regulatory process
International Journal of Technology Assessment in Health Care, 20(3), 311–324 · Published 1 August 2004 · DOI 10.1017/s0266462304001138
In brief
“EMEA and the evaluation of health-related quality of life data in the drug regulatory process” is a 2004 review article by Sotiria Papanicolaou and 2 co-authors, published in International Journal of Technology Assessment in Health Care. OpenAlex counts 10 citations as of 22 November 2026, which puts it in the top 8% of works published in 2004 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 10
- Most cited in
- 2022 (2)
- Field-weighted impact
- 0.30
- References
- 27
- Authors
- 3
Abstract
OBJECTIVES: This study reviewed the European guidelines of the Committee for Proprietary Medicinal Products (CPMP) on how health-related quality of life (HRQOL) research should be conducted in clinical trials. Published product-level information was also reviewed to investigate the actual role of HRQOL data in the European regulatory process. METHODS: All disease-specific notes for guidance and… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Papanicolaou, S., Sykes, D. B., & Mossialos, E. A. (2004). EMEA and the evaluation of health-related quality of life data in the drug regulatory process. International Journal of Technology Assessment in Health Care, 20(3), 311–324. https://doi.org/10.1017/s0266462304001138
MLA 9
Papanicolaou, Sotiria, et al. “EMEA and the evaluation of health-related quality of life data in the drug regulatory process.” International Journal of Technology Assessment in Health Care, vol. 20, no. 3, 2004, pp. 311–324. https://doi.org/10.1017/s0266462304001138.
Chicago
Papanicolaou, Sotiria, David B. Sykes, and Elias A. Mossialos. 2004. “EMEA and the evaluation of health-related quality of life data in the drug regulatory process.” International Journal of Technology Assessment in Health Care 20 (3): 311–324. https://doi.org/10.1017/s0266462304001138.
Harvard
Papanicolaou, S., Sykes, D. B. and Mossialos, E. A. (2004) ‘EMEA and the evaluation of health-related quality of life data in the drug regulatory process’, International Journal of Technology Assessment in Health Care, 20(3), pp. 311–324. doi:10.1017/s0266462304001138.
IEEE
S. Papanicolaou, D. B. Sykes, and E. A. Mossialos, “EMEA and the evaluation of health-related quality of life data in the drug regulatory process,” International Journal of Technology Assessment in Health Care, vol. 20, no. 3, pp. 311–324, 2004, doi: 10.1017/s0266462304001138.
BibTeX
@article{papanicolaou2004emea,
title = {{EMEA and the evaluation of health-related quality of life data in the drug regulatory process}},
author = {Papanicolaou, Sotiria and Sykes, David B. and Mossialos, Elias A.},
journal = {International Journal of Technology Assessment in Health Care},
year = {2004},
volume = {20},
number = {3},
pages = {311--324},
doi = {10.1017/s0266462304001138},
url = {https://doi.org/10.1017/s0266462304001138}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- health-related quality of life
- drug regulation
- European Medicines Agency
- regulatory guidelines
- clinical trials
- European Public Assessment Reports
- health outcomes
- drug approval
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Papanicolaou, S., Sykes, D. B., & Mossialos, E. A. (2004). EMEA and the evaluation of health-related quality of life data in the drug regulatory process. International Journal of Technology Assessment in Health Care, 20(3), 311–324. https://doi.org/10.1017/s0266462304001138
How many times has this paper been cited?
10 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Sotiria Papanicolaou, David B. Sykes, Elias A. Mossialos.
What is the DOI of this paper?
10.1017/s0266462304001138, permanently at https://doi.org/10.1017/s0266462304001138. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.